Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

    Virtual Booth

    Contact Supplier

    Evonik

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-02-24

    Virtual Booth

    Contact Supplier

    Menu

    Insulin Detemir

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Senators want to know more on why Novo is discontinuing its insulin Levemir
    Senators want to know more on why Novo is discontinuing its insulin Levemir

    20 Apr 2024

    // Katherine Lewin ENDPTS

    https://endpts.com/senate-democrats-question-why-novo-discontinued-its-long-acting-insulin-levemir/

    Katherine Lewin ENDPTS
    20 Apr 2024
    Share Share
    Novo Nordisk to slash US insulin prices, following move by Eli Lilly
    Novo Nordisk to slash US insulin prices, following move by Eli Lilly

    15 Mar 2023

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-cut-price-insulin-by-up-75-wsj-2023-03-14/

    REUTERS
    15 Mar 2023
    Share Share
    Novo Nordisk's Biologic Levemir Innolet (Insulin Detemir) Receives Approval in the U.S.
    Novo Nordisk's Biologic Levemir Innolet (Insulin Detemir) Receives Approval in the U.S.

    08 Dec 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021536

    FDA
    08 Dec 2022
    Share Share
    Novo Nordisk Issues Voluntary Nationwide Recall of Levemir®
    Novo Nordisk Issues Voluntary Nationwide Recall of Levemir®

    11 May 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/novo-nordisk-issues-voluntary-nationwide-recall-of-levemir-1620795213.pdf

    FDA
    11 May 2021
    Share Share
    Novo faces shareholder suit over insulin sales disclosures
    Novo faces shareholder suit over insulin sales disclosures

    16 Aug 2019

    // Ned Pagliarulo BIOPHARMADIVE

    https://www.biopharmadive.com/news/novo-faces-shareholder-suit-over-insulin-sales-disclosures/561091/

    Ned Pagliarulo BIOPHARMADIVE
    16 Aug 2019
    Share Share
    Novo Nordisk preps for speedy oral GLP-1 drug filing
    Novo Nordisk preps for speedy oral GLP-1 drug filing

    01 Feb 2019

    // PM LIVE

    http://www.pmlive.com/pharma_news/novo_nordisk_preps_for_speedy_oral_glp-1_drug_filing_1277020

    PM LIVE
    01 Feb 2019
    Share Share